- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03465566
Emotion Recognition in Benign Epilepsy of Childhood With Centro-Temporal Spikes (BECTS) (BECTS)
Facial Emotion Decoding in Benign Partial Epilepsy of Childhood With Centrotemporal Spikes
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study design: Multicentre, Case-control study.
Emotion recognition is a first step for the development of the capacity to judge the thoughts, intentions, and desires of others. In infants, the capacity to identify, distinguish, and interpret emotions is limited, but these processes are developing rapidly and innately during the first years of life, on the same neural bases as those described in adulthood. Children with BECTS show altered social behavior. In fact, deficit in social cognition could derive from brain dysfunction in the frontotemporal regions primarily affected in BECTS, since these regions are also viewed as playing an important role in social cognition and development of social skills.
The investigators hypothesized that children with BECTS might have altered social cognitive skills and underlying neural networks.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
Isernia
-
Pozzilli, Isernia, Italy, 86077
- Recruiting
- IRCCS Neuromed
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- children diagnosed with active BECTS (e.g. having at least one seizure with epileptiform abnormalities at EEG)
- treated or not with anti-epileptic drugs; age range between 6 and 11
- infants who have not presented an epileptic seizure within 48 hours before the psychodiagnostic evaluation
- patients with a sleep EEG recording; MMSPE (Mini Mental State Pediatric Examination) ≥23.3
Exclusion Criteria:
- mental retardation
- presence of other neurological or severe neuropsychiatric disorders
- atypical EEG pattern (awake or asleep)
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Children with BECTS
Children with active BECTS according to state-of-the-art diagnostic criteria of ILAE (International League Against Epilepsy). Eligible subjects will be recruited at their first clinical observation in the epilepsy centers involved in the study. All subjects will perform five diagnostic evaluations named: IDS (Intelligence and Development Scale) MMSPE (Mini Mental State Pediatric Examination) CDI 2 (Children Depression Inventory 2) CBCL (Child Behavior Check List) Tests of facial expression evaluation |
Five pictures (including nonfacial features; i.e., hairs) were used for each emotion, giving a total of 25 trials.Stimuli consist of pictures of facial affect taken from the Ekman and Friesen series.
|
|
Healthy children
Healthy controls matched for sex, age range, and education with no family history for epilepsy or other neuropsychiatric disorders. All subjects will perform the following tests: MMSPE (Mini Mental State Pediatric Examination) CDI 2 (Children Depression Inventory 2) CBCL (Child Behavior Check List) Tests of facial expression evaluation |
Five pictures (including nonfacial features; i.e., hairs) were used for each emotion, giving a total of 25 trials.Stimuli consist of pictures of facial affect taken from the Ekman and Friesen series.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number (total amount) of errors in facial emotion recognition
Time Frame: an average of 1 year
|
A neuropsychologist will sign the number of errors in recognizing each facial emotion expression
|
an average of 1 year
|
|
Rating of the intensity of facial expressions
Time Frame: an average of 1 year
|
A neuropsychologist will ask the subjects to rate (on a scale from 0 = not at all to 5 = very much) each stimulus with respect to the prototypical expression of that emotion
|
an average of 1 year
|
|
Rating of the arousal of facial expressions
Time Frame: an average of 1 year
|
A neuropsychologist will ask the subjects to evaluate arousal in terms of feeling of high-low energy/wakefulness/alertness by rating each stimulus on a 9-point scale.
|
an average of 1 year
|
|
Rating of the valence of facial expressions
Time Frame: an average of 1 year
|
A neuropsychologist will ask the subjects to evaluate valence in terms of feeling of high-low pleasantness-unpleasantness by rating each stimulus on a 9-point scale.
|
an average of 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
EEG abnormality lateralization and facial emotion recognition
Time Frame: an average of 1 year
|
The investigators will include in statistical analysis the side (dominant hemisphere vs. non-dominant) of EEGraphic abnormalities on awake/sleep recordings
|
an average of 1 year
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Giancarlo Di Gennaro, MD, PhD, IRCCS Neuromed
Publications and helpful links
General Publications
- De Risi M, Di Gennaro G, Picardi A, Casciato S, Grammaldo LG, D'Aniello A, Lanni D, Meletti S, Modugno N. Facial emotion decoding in patients with Parkinson's disease. Int J Neurosci. 2018 Jan;128(1):71-78. doi: 10.1080/00207454.2017.1366475. Epub 2017 Aug 28.
- Meletti S, Picardi A, De Risi M, Monti G, Esposito V, Grammaldo LG, Di Gennaro G. The affective value of faces in patients achieving long-term seizure freedom after temporal lobectomy. Epilepsy Behav. 2014 Jul;36:97-101. doi: 10.1016/j.yebeh.2014.05.002. Epub 2014 Jun 2.
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- DGN01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Epilepsy, Rolandic
-
Massachusetts General HospitalBoston University; National Institute of Neurological Disorders and Stroke...CompletedEpilepsy | Epilepsy; Seizure | Rolandic Epilepsy | Rolandic Epilepsy, Benign | Centrotemporal Epilepsy | Centrotemporal; EEG Spikes, Epilepsy of ChildhoodUnited States
-
King's College LondonKing's College Hospital NHS Trust; The Hospital for Sick Children; Cardiff University and other collaboratorsCompletedRolandic EpilepsyUnited States, United Kingdom, Argentina, Canada, Greece, Italy, Spain
-
King's College LondonNational Institute of Neurological Disorders and Stroke (NINDS)Completed
-
King's College LondonKing's College Hospital NHS Trust; Oxford Brookes University; University of Liverpool and other collaboratorsTerminatedRolandic EpilepsyUnited Kingdom
-
Janssen Korea, Ltd., KoreaCompleted
-
Medical University of South CarolinaCompletedEpilepsy | Seizures | Rolandic Epilepsy | Benign Childhood Epilepsy With Centrotemporal SpikesUnited States
-
University of Campinas, BrazilFundação de Amparo à Pesquisa do Estado de São PauloUnknownApraxia | Rolandic EpilepsyBrazil
-
Maastricht University Medical CenterEpilepsiecentrum KempenhaegheCompletedRolandic Epilepsy | Landau-Kleffner Syndrome | Nocturnal Frontal Lobe Epilepsy | Electrical Status Epilepticus During Slow Wave SleepNetherlands
-
Ludwig-Maximilians - University of MunichTerminated